HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Adjunctive hyperbaric oxygen therapy with reconstruction of lower eyelid for basal cell carcinoma: A case series.

AbstractINTRODUCTION:
Basal cell carcinoma (BCC) is among the most widespread non-melanoma skin cancers, with an incidence of around 80 % worldwide. Surgery is the main therapy of choice. High-pressure oxygen is used in hyperbaric oxygen therapy (HBO) to treat hypoxic tissue conditions. By using this technique, the tissue oxygen tensions increase. This is used to treat a wide range of diseases and disorders brought on by hypoxic states, circulation issues, inadequate tissue oxygenation due to vascular damage, tissue damage from infections or accidents, and impairment of tissue healing.
CASES PRESENTATION:
This paper presents five cases of HBO used in the healing BCC surgery. All patients underwent wide and deep excisions with eight adjunctive sessions of HBO therapy.
CLINICAL DISCUSSION:
The five cases of post-surgery wound healing improved significantly with HBO.
CONCLUSION:
BCC is a condition that is frequently identified in the outpatient department. Prerequisites for a better prognosis include early diagnosis based on sound information and prompt, structured, and sufficient therapy. Our study reveals the benefit of HBO in increasing wound healing and preventing complications after surgery for BCC.
AuthorsMendy Hatibie Oley, Maximillian Christian Oley, Deborah Florencia Gunawan, Andi A Rangan, Angelica Maurene Joicetine Wagiu, Muhammad Faruk
JournalInternational journal of surgery case reports (Int J Surg Case Rep) Vol. 103 Pg. 107890 (Feb 2023) ISSN: 2210-2612 [Print] Netherlands
PMID36642024 (Publication Type: Journal Article)
CopyrightCopyright © 2023 The Authors. Published by Elsevier Ltd.. All rights reserved.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: